Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
Morgan Stanley Believes Cytokinetics (NASDAQ: CYTK) Still Has Room to Grow
11:32am, Monday, 27'th Apr 2020
In a report issued on April 23,
Jeffrey Hung
from Morgan Stanley maintained a
Buy
rating on Cytokinetics (
CYTK
–
Research Report
), with a price target of
$25.00
. The company’s shares closed las
Nuveen Asset Management LLC Sells 174,381 Shares of Cytokinetics, Inc. (NASDAQ:CYTK)
10:56am, Monday, 27'th Apr 2020
Nuveen Asset Management LLC lessened its holdings in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 41.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange C
HC Wainwright Reiterates "Buy" Rating for Cytokinetics (NASDAQ:CYTK)
06:28am, Sunday, 26'th Apr 2020
Cytokinetics (NASDAQ:CYTK)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research note issued to investors on Friday, AnalystRatings.com reports. Several other equiti
Peninsula drug company gets control of its ALS drug back — with money to develop it
09:41pm, Friday, 24'th Apr 2020
Robert Blum is the CEO of South San Francisco-based Cytokinetics Inc.
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Novavax (NVAX)
11:09am, Friday, 24'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Novavax (NVAX) with bullish
Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK) and Novavax (NASDAQ: NVAX)
11:09am, Friday, 24'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (
CYTK
–
Research Report
) and Novavax (
NVAX
–
Research Report
) with bullish sentime
Cytokinetics Inc:
Assenagon Asset Management S.A. Acquires Shares of 121,510 Cytokinetics, Inc. (NASDAQ:CYTK)
09:22am, Thursday, 23'rd Apr 2020
Assenagon Asset Management S.A. acquired a new stake in Cytokinetics, Inc. (NASDAQ:CYTK) during the first quarter, according to its most recent filing with the SEC. The firm acquired 121,510 shares of
Cytokinetics to Announce First Quarter Results on May 6, 2020
08:00pm, Wednesday, 22'nd Apr 2020
Cytokinetics, Incorporated (CYTK) today announced that it is scheduled to report first quarter results on May 6, 2020 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior manag
Cytokinetics to Announce First Quarter Results on May 6, 2020
08:00pm, Wednesday, 22'nd Apr 2020
SOUTH SAN FRANCISCO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report...
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX;CYTK;GILD
12:47pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX CYTK GILD
Agile Therapeutics Announces Changes to its Board of Directors
12:00pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon Barbari for election as a class III director to replace Abhijeet
Cytokinetics to Announce First Quarter Results on May 6, —…—…
12:00am, Wednesday, 22'nd Apr 2020First Citizens Bank & Trust Co. Grows Stock Position in Cytokinetics, Inc. (NASDAQ:CYTK)
10:34am, Tuesday, 21'st Apr 2020
First Citizens Bank & Trust Co. lifted its stake in Cytokinetics, Inc. (NASDAQ:CYTK) by 24.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exc
